Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 38,620 | 37,930 | 39,467 | 38,505 | 38,442 |
| Cost of Goods | 13,192 | 14,356 | 14,189 | 10,765 | 9,991 |
| Gross Profit | 25,428 | 23,574 | 25,278 | 27,740 | 28,451 |
| Operating Expenses | 88,687 | 85,526 | 81,792 | 78,270 | 70,722 |
| Operating Income | -63,067 | -61,596 | -56,325 | -49,765 | -41,280 |
| Other Income | 271 | 239 | 327 | 464 | 638 |
| Pre-tax Income | -62,796 | -61,357 | -55,998 | -49,301 | -40,642 |
| Net Income Continuous | -62,796 | -61,357 | -55,998 | -49,301 | -40,642 |
| Minority Interests | -60 | 76 | -95 | N/A | N/A |
| Net Income | $-62,736 | $-61,433 | $-55,903 | $-49,301 | $-40,642 |
| EPS Basic Total Ops | -0.44 | -0.44 | -0.40 | -0.35 | -0.29 |
| EPS Basic Continuous Ops | -0.44 | -0.44 | -0.40 | -0.35 | -0.29 |
| EPS Diluted Total Ops | -0.44 | -0.44 | -0.40 | -0.35 | -0.29 |
| EPS Diluted Continuous Ops | -0.44 | -0.44 | -0.40 | -0.35 | -0.29 |
| EBITDA(a) | $-57,149 | $-55,470 | $-51,015 | $-44,794 | $-36,501 |